Deadline: 23-Jun-2026
The Visiting Professorship Program (USA) provides up to $50,000 per organization to support community-based urology and medical oncology teams in delivering expert-led educational sessions on prostate cancer care. The programme focuses on improving germline and somatic testing practices, clinical decision-making, and integration of genetic testing into routine oncology workflows.
Overview
The Visiting Professorship Program is a medical education grant initiative supporting community-based prostate cancer care teams in the United States. It enables organisations to host expert-led training sessions focused on improving the use of genetic and molecular testing in prostate cancer management.
The programme is funded by Pfizer and is designed to strengthen clinical knowledge in real-world healthcare settings.
Programme Objectives
The initiative aims to:
- Improve prostate cancer care through advanced education
- Enhance understanding of germline, somatic, and genetic testing
- Support better patient selection for testing
- Improve patient communication on test results and risks
- Integrate testing into clinical workflows
- Address financial and reimbursement barriers
- Strengthen multidisciplinary care in community settings
Key Focus Areas
1. Genetic and Molecular Testing in Prostate Cancer
- Germline testing
- Somatic testing
- Clinical interpretation of genetic results
2. Patient Selection and Clinical Decision-Making
- Who to test
- When to test
- Risk-based assessment strategies
3. Patient Communication
- Explaining risks and benefits
- Sharing test results
- Family counseling implications
4. Clinical Workflow Integration
- Use of digital decision-support tools
- Involvement of advanced practice providers
- Embedding testing in routine care pathways
5. Financial and Access Barriers
- Insurance coverage issues
- Reimbursement challenges
- Cost-related barriers to testing
Programme Structure
- Session format: 2.5 to 3-hour educational program
- Delivery: Led by 1–2 Visiting Professors
- Focus: Site-specific education based on organizational needs
- Format: In-person or structured professional education sessions
Funding Details
- Total programme budget: $250,000 USD
- Number of awards: 5–7 organizations
- Maximum per award: Up to $50,000 USD
- Purpose: Support education delivery and related activities
Who Can Apply?
Eligible Organizations
- Community-based urology practices
- Community-based medical oncology organizations
- US-based prostate cancer care providers
Eligibility Requirements
Applicants must:
- Be located in the United States
- Be legally able to receive funding from Pfizer
- Be organizations providing prostate cancer care
- Have qualified medical leadership
Eligible Medical Professionals
Applicants must have:
- MD, DO, MBBS, NP, or equivalent qualification
- Active clinical practice in urology or medical oncology
- Experience treating prostate cancer patients
- Role as Chair of the educational programme
Programme Participation Model
- One or two Visiting Professors per session
- Collaboration between academic experts and community clinicians
- Focus on real-world clinical gaps
- Multidisciplinary participation encouraged
Expected Outcomes
The programme aims to deliver:
- Improved clinician knowledge in genetic testing
- Better integration of precision oncology tools
- Enhanced patient counseling practices
- More efficient clinical workflows
- Reduced barriers to testing access
- Improved prostate cancer care quality
Selection Criteria
Applications are evaluated based on:
- Strength of educational need
- Relevance to prostate cancer care gaps
- Quality of proposed programme design
- Feasibility of implementation
- Clinical impact potential
- Multidisciplinary engagement
Common Mistakes to Avoid
- Weak alignment with prostate cancer testing education
- Lack of clear clinical need
- Missing qualified physician leadership
- Poorly defined session structure
- No workflow integration strategy
Tips for Strong Applications
- Clearly define clinical gaps in your setting
- Show how education will change practice
- Include multidisciplinary team involvement
- Focus on real-world implementation
- Highlight barriers and solutions in testing access
FAQs
1. What is the maximum funding per project?
Up to $50,000 USD per organization.
2. How many projects will be funded?
Between 5 and 7 organizations.
3. Who can apply?
Community-based urology or medical oncology organizations in the United States.
4. What is the session format?
A 2.5 to 3-hour expert-led educational programme.
5. Who delivers the training?
One or two Visiting Professors with relevant expertise.
6. What is the main focus area?
Prostate cancer care, especially genetic and molecular testing.
7. Can non-US organizations apply?
No, eligibility is restricted to US-based organizations.
Conclusion
The Visiting Professorship Program strengthens prostate cancer care in community settings by improving clinician understanding of genetic testing and precision oncology. Through expert-led education, it bridges academic knowledge and real-world practice, enabling better patient outcomes and more effective clinical decision-making.
For more information, visit Pfizer.